von Beckerath N - Search Results

1

Plasminogen activator inhibitor-1 4G/5G polymorphism and efficacy of reperfusion therapy in acute myocardial infarction.

Sibbing D, von Beckerath O, von Beckerath N, Koch W, Mehilli J, Schwaiger M, Schömig A, Kastrati A. Sibbing D, et al. Among authors: von beckerath n, von beckerath o. Blood Coagul Fibrinolysis. 2005 Oct;16(7):511-5. doi: 10.1097/01.mbc.0000186838.16551.ad. Blood Coagul Fibrinolysis. 2005. PMID: 16175011 Clinical Trial.

2

CD14 gene -159C/T polymorphism is not associated with coronary artery disease and myocardial infarction.

Koch W, Kastrati A, Mehilli J, von Beckerath N, Schömig A. Koch W, et al. Among authors: von beckerath n. Am Heart J. 2002 Jun;143(6):971-6. doi: 10.1067/mhj.2002.122512. Am Heart J. 2002. PMID: 12075251

3

4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and risk of restenosis after coronary artery stenting.

Böttiger C, Koch W, Lahn C, Mehilli J, von Beckerath N, Schömig A, Kastrati A. Böttiger C, et al. Among authors: von beckerath n. Am Heart J. 2003 Nov;146(5):855-61. doi: 10.1016/S0002-8703(03)00363-6. Am Heart J. 2003. PMID: 14597935

4

PlA polymorphism of the glycoprotein IIIa and efficacy of reperfusion therapy in patients with acute myocardial infarction.

Gorchakova O, Koch W, Mehilli J, von Beckerath N, Schwaiger M, Schömig A, Kastrati A. Gorchakova O, et al. Among authors: von beckerath n. Thromb Haemost. 2004 Jan;91(1):141-5. doi: 10.1160/TH03-06-0341. Thromb Haemost. 2004. PMID: 14691579 Clinical Trial.

5

ABO locus O1 allele and risk of myocardial infarction.

von Beckerath N, Koch W, Mehilli J, Gorchakova O, Braun S, Schömig A, Kastrati A. von Beckerath N, et al. Blood Coagul Fibrinolysis. 2004 Jan;15(1):61-7. doi: 10.1097/00001721-200401000-00010. Blood Coagul Fibrinolysis. 2004. PMID: 15166945

6

Tissue factor promotor polymorphism -603 A/G is associated with myocardial infarction.

Ott I, Koch W, von Beckerath N, de Waha R, Malawaniec A, Mehilli J, Schömig A, Kastrati A. Ott I, et al. Among authors: von beckerath n. Atherosclerosis. 2004 Nov;177(1):189-91. doi: 10.1016/j.atherosclerosis.2004.07.006. Atherosclerosis. 2004. PMID: 15488883

7

P2Y12 gene H2 haplotype is not associated with increased adenosine diphosphate-induced platelet aggregation after initiation of clopidogrel therapy with a high loading dose.

von Beckerath N, von Beckerath O, Koch W, Eichinger M, Schömig A, Kastrati A. von Beckerath N, et al. Among authors: von beckerath o. Blood Coagul Fibrinolysis. 2005 Apr;16(3):199-204. doi: 10.1097/01.mbc.0000164429.21040.0a. Blood Coagul Fibrinolysis. 2005. PMID: 15795539

8

Platelet function in clopidogrel-treated patients with acute coronary syndrome.

Sibbing D, von Beckerath O, Schömig A, Kastrati A, von Beckerath N. Sibbing D, et al. Among authors: von beckerath n, von beckerath o. Blood Coagul Fibrinolysis. 2007 Jun;18(4):335-9. doi: 10.1097/MBC.0b013e3280d21aed. Blood Coagul Fibrinolysis. 2007. PMID: 17473574 Clinical Trial.

9

G protein beta 3 subunit 825T allele carriage and risk of coronary artery disease.

von Beckerath N, Schusterschitz Y, Koch W, Griesser K, Mehilli J, Gorchakova O, Schömig A, Kastrati A. von Beckerath N, et al. Atherosclerosis. 2003 Mar;167(1):135-9. doi: 10.1016/s0021-9150(02)00422-7. Atherosclerosis. 2003. PMID: 12618278

10

Association of a genetic variant of endothelial nitric oxide synthase with the 1 year clinical outcome after coronary stent placement.

Gorchakova O, Koch W, von Beckerath N, Mehilli J, Schömig A, Kastrati A. Gorchakova O, et al. Among authors: von beckerath n. Eur Heart J. 2003 May;24(9):820-7. doi: 10.1016/s0195-668x(02)00824-2. Eur Heart J. 2003. PMID: 12727149

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters